Row:	March 30,
2019
	March 31,
2018
Row:(In thousands, except per share data)
ASSETS
		Row:Current assets:
Cash and cash equivalents (Notes 1 & 3) Accounts receivable, less allowance of $40 and $134 as of March 30, 2019 and
March 31, 2018, respectively 	$ 711,035 378,172 	$ 926,037
345,957
Row:Inventories (Notes 1 & 4) 	511,793 	472,292
Row:Prepaid expenses 	25,766 	23,909
Row:Other receivables (Note 1) 	21,934 	44,795
Row:Other current assets (Notes 1 & 9) Total current assets 	36,141 1,684,841 	30,815
1,843,805
Row:Property and equipment, net (Notes 1 & 5) Goodwill (Notes 1, 6 & 7) 	1,366,513 2,173,889 	1,374,112
2,173,889
Row:Intangible assets, net (Notes 1, 6 & 7) Long-term investments (Notes 1 & 3) 	408,210 97,786 	860,336
63,765
Row:Other non-current assets (Notes 9 & 12) 	76,785 	65,612
Row:Total assets 	$5,808,024 	$6,381,519
Row:LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
		Row:Accounts payable Accrued liabilities (Notes 1, 9 & 11) Other current liabilities (Note 12) Total current liabilities Long-term debt (Note 8) Deferred tax liabilities (Note 12) 	$ 233,307 160,516 41,791 435,614 919,270 333 	$ 213,193
167,182
60,904
441,279
983,290
63,084
Row:Other long-term liabilities (Notes 9, 11 & 12) 	93,128 	118,302
Row:Total liabilities Commitments and contingent liabilities (Note 10)
Stockholders’ equity:
	1,448,345 	1,605,955
Row:Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and
outstanding 	— 	—
Row:Common stock and additional paid-in capital, $.0001 par value; 405,000 shares
authorized; 119,063 and 126,322 shares issued and outstanding at March 30,
2019 and March 31, 2018, respectively Accumulated other comprehensive loss, net of tax Accumulated deficit 	4,687,455 (6,624) (321,152) 	5,237,085
(2,752)
(458,769)
Row:Total stockholders’ equity 	4,359,679 	4,775,564
Row:Total liabilities and stockholders’ equity 	$5,808,024 	$6,381,519
Row:outstanding Common stock and additional paid-in capital, $.0001 par value; 405,000 shares
	— —
Row:authorized; 119,063 and 126,322 shares issued and outstanding at March 30,
	Row:2019 and March 31, 2018, respectively 	4,687,455 5,237,085
Row:Accumulated other comprehensive loss, net of tax 	(6,624) (2,752)
Row:Accumulated deficit Total stockholders’ equity 	(321,152) (458,769)
4,359,679 4,775,564
Row:Total liabilities and stockholders’ equity 	$5,808,024 $6,381,519
Row:Fiscal Year 	2019 	2018 	2017
Row:(In thousands, except per share data)
			Row:Revenue 	$3,090,325 	$2,973,536 	$3,032,574
Row:Cost of goods sold 	1,895,142 	1,826,570 	1,897,062
Row:Gross profit 	1,195,183 	1,146,966 	1,135,512
Row:Operating expenses:
			Row:Research and development 	450,482 	445,103 	470,836
Row:Selling, general and administrative 	476,074 	527,751 	545,588
Row:Other operating expense (Note 11) 	52,161 	103,830 	31,029
Row:Total operating expenses 	978,717 	1,076,684 	1,047,453
Row:Operating income 	216,466 	70,282 	88,059
Row:Interest expense (Note 8) 	(43,963) 	(59,548) 	(58,879)
Row:Interest income 	10,971 	7,017 	1,212
Row:Other expense (Note 8) 	(91,682) 	(606) 	(3,087)
Row:Income before income taxes 	$ 91,792 $ 	17,145 $ 	27,305
Row:Income tax benefit (expense) (Note 12) 	41,333 	(57,433) 	(43,863)
Row:Net income (loss) 	$ 133,125 $ 	(40,288) $ 	(16,558)
Row:Net income (loss) per share (Note 13):
Basic 	$ 1.07 $ 	(0.32) $ 	(0.13)
Row:Diluted 	$ 1.05 $ 	(0.32) $ 	(0.13)
Row:Weighted average shares of common stock outstanding (Note 13):
Basic 	124,534 	126,946 	127,121
Row:Diluted 	127,356 	126,946 	127,121
Row:Fiscal Year 	2019 2018 	2017
Row:(In thousands)
		Row:Cash flows from operating activities:
Net income (loss) $ Adjustments to reconcile net income (loss) to net cash provided by operating
activities:
	133,125 $ (40,288) 	$ (16,558)
Row:Depreciation 	208,646 174,425 	209,825
Row:Intangible assets amortization (Note 7) 	454,451 539,790 	494,752
Row:Loss on debt extinguishment (Note 8) 	90,201 928 	—
Row:Deferred income taxes 	(70,169) (32,248) 	(28,027)
Row:Foreign currency adjustments 	(2,376) 953 	(36)
Row:Asset impairment (Note 11) 	15,901 46,315 	—
Row:Stock-based compensation expense 	71,580 68,158 	88,845
Row:Other, net 	5,087 3,792 	7,122
Row:Changes in operating assets and liabilities:
		Row:Accounts receivable, net 	(32,119) 12,906 	(36,873)
Row:Inventories 	(39,590) (41,887) 	(6,442)
Row:Prepaid expenses and other current and non-current assets 	13,343 28,310 	20,285
Row:Accounts payable 	15,167 38,952 	(1,035)
Row:Accrued liabilities 	(3,899) (2,623) 	26,866
Row:Income taxes payable and receivable 	(38,206) 50,801 	13,414
Row:Other liabilities Net cash provided by operating activities 	(10,778) 4,236 810,364 852,520 	4,682
776,820
Row:Investing activities:
Purchase of property and equipment 	(220,937) (269,835) 	(552,702)
Row:Purchase of available-for-sale securities 	(132,732) — 	(469)
Row:Proceeds from sales and maturities of available-for-sale debt securities 	133,132 — 	186,793
Row:Purchase of business, net of cash acquired (Note 6) 	— — 	(117,994)
Row:Other investing Net cash used in investing activities 	(27,017) (7,574) (247,554) (277,409) 	(5,976)
(490,348)
Row:Financing activities:
Repurchase and payment of debt (Note 8) Proceeds from debt issuances (Note 8) Repurchase of common stock, including transaction costs (Note 15) 	(1,050,680) (107,729) 905,350 100,000 (638,074) (219,907) 	—
—
(209,357)
Row:Proceeds from the issuance of common stock Tax withholding paid on behalf of employees for restricted stock units Other financing 	41,289 57,412 (24,835) (24,708) (9,714) (1,916) 	59,148
(15,516)
75
Row:Net cash used in financing activities Effect of exchange rate changes on cash 	(776,664) (196,848) (1,166) 2,360 	(165,650)
(1,105)
Row:Net (decrease) increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at the beginning of the period 	(215,020) 380,623 926,402 545,779 	119,717
426,062
Row:Cash, cash equivalents and restricted cash at the end of the period $ 	711,382 $ 926,402 	$ 545,779
Row:Supplemental disclosure of cash flow information:
Cash paid during the year for interest $ 	64,853 $ 70,208 	$ 71,171
Row:Cash paid during the year for income taxes $ 	69,453 $ 41,478 	$ 52,656
Row:Non-cash investing and financing information:
Capital expenditure adjustments included in liabilities $ 	37,728 $ 31,769 	$ 75,340
Row:	March 30,
2019
	March 31,
2018
Row:(In thousands, except per share data)
ASSETS
		Row:Current assets:
Cash and cash equivalents (Notes 1 & 3) Accounts receivable, less allowance of $40 and $134 as of March 30, 2019 and
March 31, 2018, respectively 	$ 711,035 378,172 	$ 926,037
345,957
Row:Inventories (Notes 1 & 4) 	511,793 	472,292
Row:Prepaid expenses 	25,766 	23,909
Row:Other receivables (Note 1) 	21,934 	44,795
Row:Other current assets (Notes 1 & 9) Total current assets 	36,141 1,684,841 	30,815
1,843,805
Row:Property and equipment, net (Notes 1 & 5) Goodwill (Notes 1, 6 & 7) 	1,366,513 2,173,889 	1,374,112
2,173,889
Row:Intangible assets, net (Notes 1, 6 & 7) Long-term investments (Notes 1 & 3) 	408,210 97,786 	860,336
63,765
Row:Other non-current assets (Notes 9 & 12) 	76,785 	65,612
Row:Total assets 	$5,808,024 	$6,381,519
Row:LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
		Row:Accounts payable Accrued liabilities (Notes 1, 9 & 11) Other current liabilities (Note 12) Total current liabilities Long-term debt (Note 8) Deferred tax liabilities (Note 12) 	$ 233,307 160,516 41,791 435,614 919,270 333 	$ 213,193
167,182
60,904
441,279
983,290
63,084
Row:Other long-term liabilities (Notes 9, 11 & 12) 	93,128 	118,302
Row:Total liabilities Commitments and contingent liabilities (Note 10)
Stockholders’ equity:
	1,448,345 	1,605,955
Row:Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and
outstanding 	— 	—
Row:Common stock and additional paid-in capital, $.0001 par value; 405,000 shares
authorized; 119,063 and 126,322 shares issued and outstanding at March 30,
2019 and March 31, 2018, respectively Accumulated other comprehensive loss, net of tax Accumulated deficit 	4,687,455 (6,624) (321,152) 	5,237,085
(2,752)
(458,769)
Row:Total stockholders’ equity 	4,359,679 	4,775,564
Row:Total liabilities and stockholders’ equity 	$5,808,024 	$6,381,519
Row:outstanding Common stock and additional paid-in capital, $.0001 par value; 405,000 shares
	— —
Row:authorized; 119,063 and 126,322 shares issued and outstanding at March 30,
	Row:2019 and March 31, 2018, respectively 	4,687,455 5,237,085
Row:Accumulated other comprehensive loss, net of tax 	(6,624) (2,752)
Row:Accumulated deficit Total stockholders’ equity 	(321,152) (458,769)
4,359,679 4,775,564
Row:Total liabilities and stockholders’ equity 	$5,808,024 $6,381,519
Row:Fiscal Year 	2019 	2018 	2017
Row:(In thousands, except per share data)
			Row:Revenue 	$3,090,325 	$2,973,536 	$3,032,574
Row:Cost of goods sold 	1,895,142 	1,826,570 	1,897,062
Row:Gross profit 	1,195,183 	1,146,966 	1,135,512
Row:Operating expenses:
			Row:Research and development 	450,482 	445,103 	470,836
Row:Selling, general and administrative 	476,074 	527,751 	545,588
Row:Other operating expense (Note 11) 	52,161 	103,830 	31,029
Row:Total operating expenses 	978,717 	1,076,684 	1,047,453
Row:Operating income 	216,466 	70,282 	88,059
Row:Interest expense (Note 8) 	(43,963) 	(59,548) 	(58,879)
Row:Interest income 	10,971 	7,017 	1,212
Row:Other expense (Note 8) 	(91,682) 	(606) 	(3,087)
Row:Income before income taxes 	$ 91,792 $ 	17,145 $ 	27,305
Row:Income tax benefit (expense) (Note 12) 	41,333 	(57,433) 	(43,863)
Row:Net income (loss) 	$ 133,125 $ 	(40,288) $ 	(16,558)
Row:Net income (loss) per share (Note 13):
Basic 	$ 1.07 $ 	(0.32) $ 	(0.13)
Row:Diluted 	$ 1.05 $ 	(0.32) $ 	(0.13)
Row:Weighted average shares of common stock outstanding (Note 13):
Basic 	124,534 	126,946 	127,121
Row:Diluted 	127,356 	126,946 	127,121
Row:Fiscal Year 	2019 2018 	2017
Row:(In thousands)
		Row:Cash flows from operating activities:
Net income (loss) $ Adjustments to reconcile net income (loss) to net cash provided by operating
activities:
	133,125 $ (40,288) 	$ (16,558)
Row:Depreciation 	208,646 174,425 	209,825
Row:Intangible assets amortization (Note 7) 	454,451 539,790 	494,752
Row:Loss on debt extinguishment (Note 8) 	90,201 928 	—
Row:Deferred income taxes 	(70,169) (32,248) 	(28,027)
Row:Foreign currency adjustments 	(2,376) 953 	(36)
Row:Asset impairment (Note 11) 	15,901 46,315 	—
Row:Stock-based compensation expense 	71,580 68,158 	88,845
Row:Other, net 	5,087 3,792 	7,122
Row:Changes in operating assets and liabilities:
		Row:Accounts receivable, net 	(32,119) 12,906 	(36,873)
Row:Inventories 	(39,590) (41,887) 	(6,442)
Row:Prepaid expenses and other current and non-current assets 	13,343 28,310 	20,285
Row:Accounts payable 	15,167 38,952 	(1,035)
Row:Accrued liabilities 	(3,899) (2,623) 	26,866
Row:Income taxes payable and receivable 	(38,206) 50,801 	13,414
Row:Other liabilities Net cash provided by operating activities 	(10,778) 4,236 810,364 852,520 	4,682
776,820
Row:Investing activities:
Purchase of property and equipment 	(220,937) (269,835) 	(552,702)
Row:Purchase of available-for-sale securities 	(132,732) — 	(469)
Row:Proceeds from sales and maturities of available-for-sale debt securities 	133,132 — 	186,793
Row:Purchase of business, net of cash acquired (Note 6) 	— — 	(117,994)
Row:Other investing Net cash used in investing activities 	(27,017) (7,574) (247,554) (277,409) 	(5,976)
(490,348)
Row:Financing activities:
Repurchase and payment of debt (Note 8) Proceeds from debt issuances (Note 8) Repurchase of common stock, including transaction costs (Note 15) 	(1,050,680) (107,729) 905,350 100,000 (638,074) (219,907) 	—
—
(209,357)
Row:Proceeds from the issuance of common stock Tax withholding paid on behalf of employees for restricted stock units Other financing 	41,289 57,412 (24,835) (24,708) (9,714) (1,916) 	59,148
(15,516)
75
Row:Net cash used in financing activities Effect of exchange rate changes on cash 	(776,664) (196,848) (1,166) 2,360 	(165,650)
(1,105)
Row:Net (decrease) increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at the beginning of the period 	(215,020) 380,623 926,402 545,779 	119,717
426,062
Row:Cash, cash equivalents and restricted cash at the end of the period $ 	711,382 $ 926,402 	$ 545,779
Row:Supplemental disclosure of cash flow information:
Cash paid during the year for interest $ 	64,853 $ 70,208 	$ 71,171
Row:Cash paid during the year for income taxes $ 	69,453 $ 41,478 	$ 52,656
Row:Non-cash investing and financing information:
Capital expenditure adjustments included in liabilities $ 	37,728 $ 31,769 	$ 75,340
